Krintafel
Chemical Name | tafenoquine |
Dosage Form | Tablet (oral; 150 mg) |
Drug Class | Antimalarials |
System | Blood |
Company | GlaxoSmithKline plc |
Approval Year | 2018 |
Indication
- To treat Plasmodium vivax malaria in conjunction with appropriate therapy for acute Plasmodium vivax in patients ≥ 16 years of age in cases that are not acute.